Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T21:42:04.493Z.
Calculation as of: 2026-10-06T21:42:04.493Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fc2e94c8beea8e322b310e9b25a1b89028fd55b2fc6a2790cf1d230843e32158
EARNINGS YIELD
N/A
Incannex Healthcare Limited
Market Cap
$37.93M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.61M
Earnings Yield
N/A
TTM Avg
0.70%
3Y Avg
1.26%
5Y Avg
6.45%
Market Cap
$38.78M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.21M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $37.93M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.61M | N/A | 0.70% | 1.26% | 6.45% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $38.78M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $36.21M | N/A | N/A | N/A | N/A |
| Veru Inc. (VERU)vs › | $39.64M | N/A | 0.74% | 0.65% | 0.64% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | N/A | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.76M | N/A | 6.97% | 4.38% | 4.29% |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.52M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
